Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
GANNET53: Ganetespib in Metastatic, p53-mutant, Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT02012192. IPD Sharing: Not stated. Countries: 4. Publications: 0.
TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02764333. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT04774380. IPD Sharing: YES. Countries: 6. Publications: 0.
Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT00408603. IPD Sharing: YES. Countries: 2. Publications: 0.
Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT01853644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer
ClinicalTrials.gov study NCT03430700. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT02591095. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT04753216. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT03132532. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally
ClinicalTrials.gov study NCT04988295. IPD Sharing: YES. Countries: 29. Publications: 0.
Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT02900560. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer
ClinicalTrials.gov study NCT01611558. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy
ClinicalTrials.gov study NCT00707655. IPD Sharing: Not stated. Countries: 3. Publications: 0.
DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT06964009. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT06899126. IPD Sharing: YES. Countries: 12. Publications: 0.
A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT05613088. IPD Sharing: YES. Countries: 9. Publications: 0.
A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa
ClinicalTrials.gov study NCT00119613. IPD Sharing: Not stated. Countries: 0. Publications: 2.
REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer
ClinicalTrials.gov study NCT03515629. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC
ClinicalTrials.gov study NCT04153734. IPD Sharing: NO. Countries: 0. Publications: 26.
BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients
ClinicalTrials.gov study NCT01624493. IPD Sharing: Not stated. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.